Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (411-420 of 754) with videos related to

Pageof 76
Sort By:
Oncogene|May 16, 2017
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cellsD Kawauchi, R J Ogg, L Liu, et al.
Extracellular Vesicles and Circulating Nucleic Acids|January 19, 2026
Preanalytical framework for routine clinical use of liquid biopsies: combining EVs and cfDNANike K Simon, Stefanie Volz, Jussara Rios de Los Rios Reséndiz, et al.
BMC Cancer|June 7, 2020
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignanciesCornelis M van Tilburg, Ruth Witt, Melanie Heiss, et al.
Journal of Translational Medicine|June 5, 2023
Group-specific cellular metabolism in MedulloblastomaViktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classificationCynthia Hawkins, Kenneth Aldape, David Capper, et al.
Acta Neuropathologica|April 5, 2014
Subgroup-specific localization of human medulloblastoma based on pre-operative MRIAnnika K Wefers, Monika Warmuth-Metz, Julia Pöschl, et al.
Acta Neuropathologica|September 30, 2025
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomasFuat Kaan Aras, Dennis Friedel, Felix Keller, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registryJonas Ecker, Florian Selt, Dominik Sturm, et al.
Biomarker Research|June 17, 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progressionGiuseppina Catanzaro, Zein Mersini Besharat, Andrea Carai, et al.
Acta Neuropathologica|October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityAndrey Korshunov, David Capper, David Reuss, et al.
Pageof 76

Showing results (411-420 of 754) with videos related to

Sort By:
Pageof 76
Oncogene|May 16, 2017
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cellsD Kawauchi, R J Ogg, L Liu, et al.
Extracellular Vesicles and Circulating Nucleic Acids|January 19, 2026
Preanalytical framework for routine clinical use of liquid biopsies: combining EVs and cfDNANike K Simon, Stefanie Volz, Jussara Rios de Los Rios Reséndiz, et al.
BMC Cancer|June 7, 2020
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignanciesCornelis M van Tilburg, Ruth Witt, Melanie Heiss, et al.
Journal of Translational Medicine|June 5, 2023
Group-specific cellular metabolism in MedulloblastomaViktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classificationCynthia Hawkins, Kenneth Aldape, David Capper, et al.
Acta Neuropathologica|April 5, 2014
Subgroup-specific localization of human medulloblastoma based on pre-operative MRIAnnika K Wefers, Monika Warmuth-Metz, Julia Pöschl, et al.
Acta Neuropathologica|September 30, 2025
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomasFuat Kaan Aras, Dennis Friedel, Felix Keller, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registryJonas Ecker, Florian Selt, Dominik Sturm, et al.
Biomarker Research|June 17, 2022
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progressionGiuseppina Catanzaro, Zein Mersini Besharat, Andrea Carai, et al.
Acta Neuropathologica|October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityAndrey Korshunov, David Capper, David Reuss, et al.
Pageof 76